Announcements Trials
Browse Landscape

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Neoplasms 4Melanoma 2Uterine Cervical Neoplasms 1Solid Tumor, Adult 1Skin Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neuromyelitis Optica 1Neoplasms, Second Primary 1Neoplasm Metastasis 1Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 1Myasthenia Gravis 1Multiple Sclerosis 1Lung Neoplasms 1Laryngectomy; Status 1Hematologic Neoplasms 1Hematologic Diseases 1Endometrial Neoplasms 1Encephalomyelitis, Acute Disseminated 1Carcinoma, Renal Cell 1COVID-19 1Breast Neoplasms 1Autoimmune Diseases of the Nervous System 1

Interventions

Nivolumab 23pembrolizumab 19Ipilimumab 13toripalimab 12Temozolomide 11Biopsy 8Dacarbazine 7Blood Specimen Collection 6trametinib 5dabrafenib 5camrelizumab 5atezolizumab 5Gene Expression Profiling 5Cyclophosphamide 5Chemotherapy, Adjuvant 5fludarabine 4durvalumab 4binimetinib 4aldesleukin 4Injections 4tislelizumab 3palbociclib 3encorafenib 3apatinib 3Sorafenib 3Introns 3Interleukin-2 3Drug Therapy 3Cisplatin 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Melanoma × Data Collection × Clear all
NCT04485442 2023-11-21

Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face

University Hospital, Basel, Switzerland

Unknown
100 enrolled
Dermatologic

Melanoma, Skin Neoplasms

NCT05641012 2022-12-07

Helioma

Institut Jean-Godinot

Unknown
100 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡